Lanzamiento Enero 2027

Ensayo controlado aleatorizado2018Financiación no declarada

Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial

Hooton TM, Vecchio M, Iroz A, Tack I, Dornic Q, Seksek I, Lotan Y

JAMA internal medicine · 115 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2018-10-03 · JAMA Intern Med · vol. 178 · número 11 · pág. 1509
Editorial
American Medical Association
Citado
271 citas · más que el 100% de estudios similares · 22.5× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
49 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Urinary Tract Infections Management · Pelvic floor disorders treatments · Urinary Bladder and Prostate Research
Palabras clave
Medicine, Randomized controlled trial, Urinary system, Confidence interval, Fluid intake, Internal medicine
MeSH
humans, urinary tract infections, recurrence, treatment outcome, premenopause, drinking, adult, female, secondary prevention

7 autores

  • Thomas M. Hooton🇺🇸 · autor de correspondenciaUniversity of Miami
  • Mariacristina Vecchio🇫🇷Danone (France)
  • Alison Iroz🇫🇷Danone (France)
  • Ivan Tack🇫🇷Université Toulouse III - Paul Sabatier; Centre Hospitalier Universitaire de Toulouse
  • Quentin Dornic🇫🇷Danone (France)
  • Isabelle Seksek🇫🇷Danone (France)
  • Yair Lotan🇺🇸The University of Texas Southwestern Medical Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

Importance

Increased hydration is often recommended as a preventive measure for women with recurrent cystitis, but supportive data are sparse.

Objective

To assess the efficacy of increased daily water intake on the frequency of recurrent cystitis in premenopausal women.

Design, setting, and participants

Randomized, open-label, controlled, 12-month trial at a clinical research center (years 2013-2016). Among 163 healthy women with recurrent cystitis (≥3 episodes in past year) drinking less than 1.5 L of fluid daily assessed for eligibility, 23 were excluded and 140 assigned to water or control group. Assessments of daily fluid intake, urinary hydration, and cystitis symptoms were performed at baseline, 6- and 12-month visits, and monthly telephone calls.

Interventions

Participants were randomly assigned to drink, in addition to their usual fluid intake, 1.5 L of water daily (water group) or no additional fluids (control group) for 12 months.

Main outcomes and measures

Primary outcome measure was frequency of recurrent cystitis over 12 months. Secondary outcomes were number of antimicrobial regimens used, mean time interval between cystitis episodes, and 24-hour urinary hydration measurements.

Results

The mean (SD) age of the 140 participants was 35.7 (8.4) years, and the mean (SD) number of cystitis episodes in the previous year was 3.3 (0.6). During the 12-month study period, the mean (SD) number of cystitis episodes was 1.7 (95% CI, 1.5-1.8) in the water group compared with 3.2 (95% CI, 3.0-3.4) in the control group, with a difference in means of 1.5 (95% CI, 1.2-1.8; P < .001). Overall, there were 327 cystitis episodes, 111 in the water group and 216 in the control group. The mean number of antimicrobial regimens used to treat cystitis episodes was 1.9 (95% CI, 1.7-2.2) and 3.6 (95% CI, 3.3-4.0), respectively, with a difference in means of 1.7 (95% CI, 1.3-2.1; P < .001). The mean time interval between cystitis episodes was 142.8 (95% CI, 127.4-160.1) and 84.4 (95% CI, 75.4-94.5) days, respectively, with a difference in means of 58.4 (95% CI, 39.4-77.4; P < .001). Between baseline and 12 months, participants in the water group, compared with those in the control group, had increased mean (SD) urine volume (1.4 [0.04] vs 0.1 [0.04] L; P < .001) and voids (2.4 [0.2] vs -0.1 [0.2]; P < .001) and decreased urine osmolality (-402.8 [19.6] vs -24.0 [19.5] mOsm/kg; P < .001).

Conclusions and relevance

Increased water intake is an effective antimicrobial-sparing strategy to prevent recurrent cystitis in premenopausal women at high risk for recurrence who drink low volumes of fluid daily.

Trial registration

ClinicalTrials.gov identifier: NCT02444975.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.